Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Sepsis Diagnosis and Treatment, Respiratory Support and Mechanisms, SARS-CoV-2 and COVID-19 Research, and Kawasaki Disease and Coronary Complications.
Heterozygous variants in DOCK2 leading to susceptibility to viral illnesses.
Characteristics of Young Children Hospitalized With Acute Respiratory Failure From Infection With Respiratory Syncytial Virus, SARS-CoV-2, or Both, November 2023-March 2024.
Global, regional, and national sepsis incidence and mortality, 1990-2021: a systematic analysis.
Influenza-Associated Acute Necrotizing Encephalopathy in US Children
Influenza-Associated Acute Necrotizing Encephalopathy in US Children.
The 2024 Phoenix Sepsis Score Criteria: Part 1, the Evolution in Definition of Sepsis and Septic Shock.
The 2024 Phoenix Sepsis Score Criteria: Part 4, What About Using World-Oriented Criteria?
Preventing, identifying, and managing sepsis in the community: research and clinical priorities
The 2024 Phoenix Sepsis Score Criteria: Part 2, What About Using Interventions in the Criteria?
The 2024 Phoenix Sepsis Score Criteria: Part 5, What About "Parsimony" in the Criteria-Is Less Really More?
Preventing, identifying, and managing sepsis in the community: research and clinical priorities
The 2024 Phoenix Sepsis Score Criteria: Part 3, What About Using Stages of Sepsis in the Criteria?
Impact of Viral Lower Respiratory Tract Infection (LRTI) in Early Childhood (0-2 Years) on Lung Growth and Development and Lifelong Trajectories of Pulmonary Health: A National Institutes of Health (NIH) Workshop Summary.
Pediatric Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy - United States, 2024-25 Influenza Season.
Use of procalcitonin in therapeutic decisions in the pediatric intensive care unit.
Neurologic and Psychological Outcomes 2 Years After Multisystem Inflammatory Syndrome in Children.
Concordance between parent-reported and documented COVID-19 vaccination status among hospitalized children and adolescents: Implications for vaccine effectiveness estimates, May 2021-October 2023.
Longitudinal Antibody Responses to SARS-CoV-2 Infection in Children: Impact of Age, Vaccines and Symptoms.
Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting.
Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025.
High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signatures.
Assessing Clinical Improvement of Infants Hospitalized for Respiratory Syncytial Virus-Related Critical Illness.
International Consensus Criteria for Pediatric Sepsis and Septic Shock
International Consensus Criteria for Pediatric Sepsis and Septic Shock.
Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock
Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock.
From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU
From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU.
Enhancing sepsis biomarker development: key considerations from public and private perspectives.